Assyro AI

FDA Orange Book · active-ingredient family

Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate

Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:MULTRYS · NDA 209376

1

Brand (NDA)

0

Generics (ANDA)

5

Listed patents

0

Exclusivity periods

Brand (NDA) products · solution

ProductApplicantApplicationTEApproved
MULTRYSRLD×3AM REGENTNDA 209376Jun 30, 2021

Listed patents (5)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12150957Jul 01, 2041in 15 yr 3 mo
U-3900
12150956Jul 01, 2041in 15 yr 3 mo
U-3900
11975022Jul 01, 2041in 15 yr 3 mo
U-3900
11786548Jul 01, 2041in 15 yr 3 mo
Product
11998565Jul 01, 2041in 15 yr 3 mo
Product

Cupric sulfate; manganese sulfate; selenious acid; zinc sulfate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.